Ribosomal protein L22 pseudogene 4 (RPL22P4)

RPL22P4 (Ribosomal protein L22 pseudogene 4) is a processed pseudogene found in the human genome, related by sequence to the functional ribosomal protein L22 gene (RPL22)[1][4][6]. Pseudogenes are genetic elements that arise from gene duplication or retrotransposition but lack the capability to encode a functional protein. RPL22P4 does not produce a protein and is not involved in ribosomal function, signaling, or any direct cellular process relevant to therapeutic targeting. Numerous ribosomal protein pseudogenes exist within the genome as remnants of evolutionary processes, but they typically have no direct functional output and are not considered viable targets for drug development or disease intervention[1][4][6]. If you are seeking information on druggable ribosomal proteins or disease-related ribosomal protein loci, consider the functional parent gene RPL22 (Ribosomal protein L22), which encodes a structural component of the 60S ribosomal subunit and has some research interest for cancer biology[5][7][3]. However, RPL22P4 specifically is not a protein, enzyme, receptor, or drug target.

Other names

RPL22_2_154RPL22P4